Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03833154
Protocol Number
C-367
Phase
III (Cancer Control)
Management Group
Oncology Network
Oncology Group
Lung Oncology Group
Disease Sites
Lung
Cancer Control
Y
Sponsor Protocol
D9103C00001
PACIFIC-4
RTOG-3515
Principal Investigator
Ioana Bonta
Scope
National
Participating Institutions
Atlanta Cancer Care - Atlanta
Atlanta Cancer Care - Cumming
Georgia Cancer Specialists - Blairsville
Georgia Cancer Specialists - Canton
Georgia Cancer Specialists - Northside
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us